Canadian best practice recommendations for the management of amyotrophic lateral sclerosis

KEY POINTS

Management of patients living with amyotrophic lateral sclerosis (ALS) requires specialized multidisciplinary holistic care.
Disease-modifying pharmacologic therapies to treat ALS include riluzole and edaravone.
Close attention to nutritional support and respiratory care is required for optimal care in ALS.
Multiple treatments are available to ease the symptoms of ALS.
Palliative care and caregiver support are important components of assisting patients along their journey with ALS.
https://www.cmaj.ca/content/192/46/E1453